Molecular design and synthesis of anti-cancer compounds that cause apoptosis
Molecular design and synthesis of anti-cancer compounds that cause apoptosis
批准号:
09672280
负责人:
OTSUKA Masami
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
细胞凋亡是由肿瘤坏死因子或Fas配体与细胞表面受体结合,通过细胞内信号转导途径诱导的细胞程序性死亡。在导致细胞凋亡的信号转导通路中,活性氧物种的参与已被推迟。本研究的目的是合成能够为肿瘤细胞信号转导途径提供活性氧的人工分子,通过在二甲氨基吡啶中引入咪唑等官能团,成功地合成了高效的氧活化分子。该合成分子对小鼠白血病L1210细胞、人白血病K562/ADM细胞、人癌细胞KB-C4、人胰腺癌ASPC-1细胞均有诱导凋亡作用,且呈时间和浓度依赖性。根据细胞的形态变化和DNA在核小体内的降解,发现细胞死亡是一种凋亡。细胞凋亡被抗氧化剂抗坏血酸抑制,这表明活性氧参与了这一过程。结果发现,caspase-1、caspase-3、bc l-2、Bax、p53和p21不参与由合成的分子诱导的细胞凋亡,从而成功地设计和合成了一种能产生活性氧物种以诱导癌细胞凋亡的人工分子。
英文摘要
Apoptosis is a programmed cell death induced through the intracellular signalling pathway caused by the binding of TNF or Fas ligand with receptors of cell surface. Involvement of active oxygen species has been postdated in the signal transduction pathway leading to apoptosis. The objective of the present research is to synthesize man-made molecules that supply active oxygen into the signalling pathway to induce apoptosis in the tumor cells.The head investigators are successful in the synthesis of highly efficient oxygen activating molecules by introducing various functional groups such as imidazole into dimethylaminopyridine. The synthesitic molecule induced apoptosis in mouse leukaemia L1210 cells, human leukaemia K562/ADM cells, human carcinoma KB-C4 cells, and human pancreatic carcinoma AsPC-1 cells depending on time and concentration. The cell death was found to be apoptosisbased on the morphological change of the cells and intranucleosomal degradation of DNA.The apoptosis was inhibited by an antioxidant ascorbic acid suggesting the involvement of active oxygen species. It was found that caspase-1, caspase-3, Bcl-2, Bax, p53, and p21 do not participate in the apoptosis caused by the synthetic molecule.Thus the head investigators are successful in the molecular design and synthesis of an artificial molecule that generates active oxygen species to induce apoptosis in carcinoma cells.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
渡辺匠: "Total synthesis of (±)-aglaiastatin,a novel bioactive alkaloid" J.Chem.Soc.,Chem.Commun.1097-1098 (1998)
Takumi Watanabe:“(±)-aglaistatin(一种新型生物活性生物碱)的全合成”J.Chem.Soc.,Chem.Commun.1097-1098 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takumi Watanabe et al.: "Total synthesis of * -aglaiastatin, a novel bioactive alkaloid" J.Chem.Soc., Chem.Commun.1998. 1097-1098 (1998)
Takumi Watanabe 等人:“* -aglaistatin(一种新型生物活性生物碱)的全合成”J.Chem.Soc.,Chem.Commun.1998。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
大塚雅巳: "Cloning and Characterization of a cDNA Encoding the Human Homolog of Tumor Necrosis Factor Receptor-Associated Factor 5(TRAF5)" Gene. 207. 135-140 (1998)
Masami Otsuka:“编码肿瘤坏死因子受体相关因子 5 (TRAF5) 人类同源物的 cDNA 的克隆和表征”基因。 207. 135-140 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Rei Suginaka et al.: "Induction of Apoptosis in Human Pancreatic Carcinoma Cells by a Synthetic Bleomycin-like Ligand" Jpn.J.Cancer Res.89. 947-953 (1998)
Rei Suginaka 等人:“通过合成博莱霉素样配体诱导人胰腺癌细胞凋亡”Jpn.J.Cancer Res.89。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masami Otsuka et al.: "Cloning and Characterization of a cDNA Encoding the Human Homolog of Tumor Necrosis Factor Receptor-Associated Factor 5 (TRAF 5)" Gene. 207. 135-140 (1998)
Masami Otsuka 等人:“编码肿瘤坏死因子受体相关因子 5 (TRAF 5) 人类同源物的 cDNA 的克隆和表征”基因。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
Design and synthesis of anti-brain tumor and brain-protective drugs using brain-targeting peptides
-
批准号:24659048
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:OTSUKA Masami
-
依托单位:
Development of medicinal molecules having biologically functions targeting the PI3K/Akt pathway and the TGF-b/Smad pathway
-
批准号:23390028
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2011
-
负责人:OTSUKA Masami
-
依托单位:
Design and synthesis of anti-HIV agents that inhibit the Vif-mediated proteasome degradation of APOBEC3G
-
批准号:22659024
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.89万
-
财政年份:2010
-
负责人:OTSUKA Masami
-
依托单位:
Design of DNA-cleaving and -crosslinking agents based on NFκB and HMGA proteins aiming at the application to cancer therapy
-
批准号:20390033
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2008
-
负责人:OTSUKA Masami
-
依托单位:
Development of zinc chelators with protein specificity aiming at molecular target therapy of cancer
-
批准号:17390030
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.12万
-
财政年份:2005
-
负责人:OTSUKA Masami
-
依托单位:
Molecular design of anti-AIDS drugs targeting the viral and host zinc proteins
-
批准号:15390038
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.51万
-
财政年份:2003
-
负责人:OTSUKA Masami
-
依托单位:
Molecular design of anti-AIDS drugs targeting the human transcription machinery employed for the replication of AIDS virus
-
批准号:12557219
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:2000
-
负责人:OTSUKA Masami
-
依托单位:
Molecular Design of Ras Farnesyltransferase Inhibitors
-
批准号:11694297
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.82万
-
财政年份:1999
-
负责人:OTSUKA Masami
-
依托单位:
Development of compounds for multiple regulation of intracellular signaling
-
批准号:11470496
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$4.22万
-
财政年份:1999
-
负责人:OTSUKA Masami
-
依托单位: